Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Sweden / NCT07634822
Starting soon Observational

Heart Failure and Postoperative Outcome in Surgery - a National Registry Study

NCT07634822 · tracked via the Priya Life Science Sweden tracker
Sponsor
Umeå University
Phase
Observational
Started
2026-08
Last updated
2026-06-09

Condition(s) studied

Heart FailureDiastolic Heart FailureSystolic Heart Failure

Study summary

The study is an exploratory study that aims to explore the incidence of heart failure in a national surgical cohort, and to compare postoperative mortality and morbidity in patients with and without heart failure. Furthermore, we want to investigate differences in the incidence of heart failure and its impact on postoperative morbidity and mortality in day surgery compared to inpatient surgery.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * ≥18 years of age who underwent surgery in Sweden between 1 Jan 2021-31 Dec 2024 and SPOR registered operation. Exclusion Criteria: * ASA 6 (deceased patient, organ donation). * Cardiac surgery

Primary outcome measure(s)

  • Postoperative mortality — 365 days
    How does a heart failure diagnosis affect postoperative mortality at 30 days, 90 days, 180 days, and 365 days?
  • Postoperative morbidity — 30 days postoperative
    How does a heart failure diagnosis associated with postoperative morbidity at 30 days?

Trial sites (2)

FacilityCityRegionStatus
Region Norrbotten, department of Anesthesia and Intensive Care, Sunderby Hospital Luleå Sweden
Institution for Diagnostic and Intervention, dep of Anestesiology and Intensive care Umeå Sweden

More Umeå University trials in Sweden

The eHealth Diabetes Remission Trial Recruiting
Clinical Effectiveness of TARA Compared to Standard Treatment for Adolescents and Young Adults With Depression Active, not recruiting
Prognostic Factors in Periampullary Tumors and Cysts Recruiting
A Comparative Study of Stem and Cup Fixation and Polyethylene Wear Active, not recruiting
Abdominal Rectus Diastasis Microscopy and Rehabilitation (AMIRE) Active, not recruiting

Other trials for the same condition

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin Recruiting
Selenium Intervention Registry Randomized Trial in Heart Failure Recruiting
Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment Recruiting
Cardiac Magnetic Resonance Stress-perfusion Study in Patinets with Fontan Circulation Recruiting
OPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosilicate in Heart Failure Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07634822 on ClinicalTrials.gov ↗ ← All trials in Sweden